• Mashup Score: 1

    Maria-Victoria Mateos, MD, PhD, University of Salamanca, Salamanca, Spain, discusses a Phase I study of teclistamab, a humanized b-cell maturation…

    Tweet Tweets with this article
    • #EHA25Virtual @mvmateos of @usal is answering questions on a phase I study of #teclistamab for RRMM @VJHemOnc caught up with her about these data. Full interview here 👉https://t.co/KxK2KPdkzc👈 @EHA_Hematology #EHA25 #EHA25Virtual #HemOnc #ImmunoOnc #MMsm #CTsm #EHAtrending https://t.co/LWlH5JFBV0

  • Mashup Score: 1

    Maria-Victoria Mateos, MD, PhD, University of Salamanca, Salamanca, Spain, discusses a Phase I study of teclistamab, a humanized b-cell maturation…

    Tweet Tweets with this article
    • Always great to speak with @mvmateos of @usal! Watch the interview on #Teclistamab for R/R multiple #Myeloma: 👉https://t.co/u8ij8MUkAV👈 @VJHemOnc @EHA_Hematology #EHA25 #EHA25Virtual #HemOnc #ImmunoOnc #MMsm #CTs #EHAtrending

  • Mashup Score: 2

    The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers

    Tweet Tweets with this article
    • #ASCO20 is starting and we’re ready to go! Watch this space for highlights from the event, including #Myeloma updates📊🎥 @VJHemOnc had a great chat w/ @szusmani on #Teclistamab & more! Interview coming shortly on 👉https://t.co/O9p0vDBrzw👈 @ASCO #MMsm #CTsm #ImmunoOnc #HemOnc https://t.co/VxQYh7Xb9M